Interestingly, we found that the expression level of NDUFS1 was weak in Stage I/II GC tumors and barely detectable in Stage III/IV GC tumors (Fig. 1e, f), indicating that the expression of NDUFS1 gradually decreased as GC progresses to more advanced stages. The gene discussed is NDUFS1; the disease is gastric cancer.